#PlatinumResistant
LightNews LightNews
onco404.bsky.social
𝐌𝐈𝐑𝐕 𝐡𝐚𝐬 𝐭𝐡𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐭𝐨 𝐛𝐞𝐜𝐨𝐦𝐞 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫-𝐝𝐫𝐢𝐯𝐞𝐧 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝-𝐨𝐟-𝐜𝐚𝐫𝐞 𝐢𝐧 𝐏𝐑𝐎𝐂, 𝐩𝐚𝐫𝐭𝐢𝐜𝐮𝐥𝐚𝐫𝐥𝐲 𝐟𝐨𝐫 𝐅𝐑α-𝐡𝐢𝐠𝐡 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬.

#Onco404 #Oncology #ClinicalTrial #CancerResearch #TargetedTherapy #GynOnc #OvarianCancer #PlatinumResistant #Healthcare #EndCancer
March 14, 2025 at 8:43 AM
thecancersurvivorsclub.com
ChemoID assay picks the winning chemo! Dramatically improved ORR in platinum-resistant ovarian cancer patients by tailoring treatment. Precision in action! #OvarianCancer #ChemoID #CancerResearch #PlatinumResistant #TCSC #OncologyBreakthrough

www.oncnursingnews.com/view/chemoth...
Chemotherapeutic Assay Selects Effective Treatments for Ovarian Cancer
Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian cancer.
www.oncnursingnews.com
April 6, 2025 at 7:17 AM
gmj-georgia.bsky.social
BREAKTHROUGH: NHS approves first new ovarian cancer treatment in 20+ years! Mirvetuximab soravtansine offers hope for women with platin…

#Mirvetuximabsoravtansine #NHS #Ovariancancer #Platinumresistant #Targetedtherapy

#Mirvetuximabsoravtansine #NHS #Ovariancancer #Platinumresistant #Targetedth…
NHS Approves First New Ovarian Cancer Drug in 20 Years
BREAKTHROUGH: NHS approves first new ovarian cancer treatment in 20+ years! Mirvetuximab soravtansine offers hope for women with platin… #Mirvetuximabsoravtansine #NHS #Ovariancancer #Platinumresistant #Targetedtherapy
news.gmj.ge
June 17, 2026 at 12:25 AM
freespkr.bsky.social
I was explaining this on Twitter. I am an #ovariancancer survivor currently on #maintenance therapy. There are currently OC patients on trials getting treatment because they have a type that is referred to as #platinumresistant. Meaning it doesn’t respond well to the first line treatment.
davelevitan.bsky.social Dave Levitan @davelevitan.bsky.social · Jan 26
"...if NCI-supported trials really are delayed or suspended for a meaningful amount of time, that means delayed discoveries, delayed drug approvals, delayed potential treatments for people whose cancer will not itself agree to such a delay."

I talk to multiple people inside NCI and NIH:
Trump's Assault on NIH Will Kill People With Cancer
Splinter is your home for news and opinions that challenge power in our political and economic system that's becoming more unhinged each and every day.
www.splinter.com
January 26, 2025 at 10:36 PM
commsbio.nature.com
New research on extracellular vesicles in ovarian cancer from Nagoya, Japan - www.nature.com/articles/s42...
Overcoming platinum-resistant ovarian cancer targeting the activated JAK-STAT pathways via extracellular vesicles - Communications Biology
Peritoneal mesothelial cell-derived extracellular vesicles provide a new mechanism for platinumresistant ovarian cancer through the enrichment of miR-135a-5p, which activates JAK-STAT signaling and suggests JAK as a key therapeutic target.
www.nature.com
September 23, 2025 at 4:00 PM